Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study.

Yun LengJian HouJie JinMei ZhangXiaoyan KeBin JiangLing PanLinhua YangFang ZhouJianmin WangZhao WangLi LiuWei LiZhixiang ShenLugui QiuNaibai ChangJianyong LiJing LiuHongyan PangHaitao MengPeng WeiHua JiangYan LiuXiangjun ZhengShifang YangWen-Ming Chen

Published in: Cancer chemotherapy and pharmacology (2017)

CPT plus TD could serve as a new therapeutic strategy for patients with RRMM. A randomized, double-blind, placebo-controlled confirmatory study is currently under way.

Keyphrases

placebo controlled
double blind
multiple myeloma
low dose
high dose
phase iii
clinical trial
phase ii
study protocol
acute lymphoblastic leukemia
phase ii study
acute myeloid leukemia
diffuse large b cell lymphoma
randomized controlled trial
squamous cell carcinoma
hodgkin lymphoma
radiation therapy